Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Brivio

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Prostaglandins & Other Lipid Mediators|February 21, 2012
The pulmonary pharmacology of [4-methoxy-N1-(4-trans-nitrooxycyclohexyl)-N3-(3-pyridinylmethyl)-1,3-benzenedicarboxamide] (2NTX-99), an anti-atherotrombotic compound with therapeutic potential in pathological conditions that target lung vasculatureI Brivio, C Buccellati, F Fumagalli, et al.
The European Physical Journal. C, Particles and Fields|February 4, 2020
ALPs effective field theory and collider signaturesI Brivio, M B Gavela, L Merlo, et al.
Physical Review Letters|November 1, 2024
Search for the Z Boson Decay to ττμμ in Proton-Proton Collisions at sqrt[s]=13  TeVA Hayrapetyan, A Tumasyan, W Adam, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Prostaglandins & Other Lipid Mediators|February 21, 2012
The pulmonary pharmacology of [4-methoxy-N1-(4-trans-nitrooxycyclohexyl)-N3-(3-pyridinylmethyl)-1,3-benzenedicarboxamide] (2NTX-99), an anti-atherotrombotic compound with therapeutic potential in pathological conditions that target lung vasculatureI Brivio, C Buccellati, F Fumagalli, et al.
The European Physical Journal. C, Particles and Fields|February 4, 2020
ALPs effective field theory and collider signaturesI Brivio, M B Gavela, L Merlo, et al.
Physical Review Letters|November 1, 2024
Search for the Z Boson Decay to ττμμ in Proton-Proton Collisions at sqrt[s]=13  TeVA Hayrapetyan, A Tumasyan, W Adam, et al.
Pageof 1